First, the term “FGF21 resistance” during human obesity, in which circulating FGF21 levels are elevated, has been controversial partly due to difficulty in delineating the physiological and pharmacological mechanisms of FGF21 (10), weight loss and energy expenditure should be assessed to test chronic FGF21 sensitivity. Here, FGF21 is linked to Obesity.